| has been working on various market research reports | | | | significant efforts in clinical research in the past few |
| pertaining to biotechnology which is their expertise and | | | | years with the development of new drugs and surgical |
| thus, concentrate only on this industry which is growing | | | | modalities of therapy as well. However, the mortality |
| at a high speed. These unique research reports are of | | | | rates remain very high. In this context, stem cell |
| immense value to investment banks, companies, | | | | applications in cardiology assume great significance |
| management consultants, trade associations, corporate | | | | since stem cells have been found to be successfully |
| executives, business analysts, libraries, universities, and | | | | used in tissue regeneration. Heart disease, including |
| business schools. | | | | myocardial infarction and ischemia, can be treated with |
| This report specifies the importance of Stem Cell | | | | the applications of stem cells. |
| Research in Cardiology. The study is segmented by | | | | The concept of stem cell transplantation to regenerate |
| Source (Allogenic and Autogenic) and by Type (Bone | | | | the myocardium and better the working of the heart |
| Marrow Stem Cells, Embryonic Stem Cells, and Other). | | | | has received a great deal of attention in recent times. |
| Projections and estimates are graphically illustrated by | | | | Small-scale studies in the pre-clinical and clinical stages |
| geographic region encompassing North America, | | | | support the use of stem cells in treating heart disease. |
| Europe, Asia-Pacific, and Rest of World. Business | | | | However similar such studies must be carried out on a |
| profiles of 23 major companies are discussed in the | | | | larger-scale to corroborate the findings and prove |
| report. The report serves as a guide to global market | | | | stem cell therapy as a viable alternative method of |
| for Stem Cell Research in Cardiology covering 229 | | | | treating patients with heart disease. |
| companies that are engaged in stem cell R&D, | | | | The global market for Stem Cells in Cardiology is |
| storage, banking, discovery, testing and supply of | | | | projected to reach about US$ 3.5 billion by 2012. Adult |
| products and services. Major Contract Research | | | | stem cells market is the largest tapped market while |
| Organizations and Universities serving the industry are | | | | cord blood and embryonic stem cell markets, though |
| also covered in the Corporate Directory section of this | | | | with huge market potential, are still in infancy stages. |
| report. Information related to recent product releases, | | | | Embryonic stem cells to treat cardiac disorders is a |
| product developments, partnerships, collaborations, | | | | very interesting area of research. However, due to |
| mergers and acquisitions, ethical issues, regulatory | | | | various ethical issues, this area is mired in debates all |
| affairs, and other areas of concern is also covered in | | | | over the world. |
| the report. Exhibits (27) complement the text. | | | | A free sample of report is available on request sent |
| Heart disease has assumed great magnitude as an | | | | through their website - Stem Cell Research in |
| endemic health problem. Cardiology field has seen | | | | Cardiology. |